However, when the activation of the NF-κB pathway was inhibited from weaning onward, the diabetes incidence was similar in Dox-treated and in untreated NOD/ToIβ mice (Fig. 3D, 3–35 weeks vs control). The gene discussed is NFKB1; the disease is diabetes mellitus.